Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Mutations in SARS-CoV

View through CrossRef
The coronavirus family is named for the large spike protein molecules found on the pathogen exterior, which give the virus a crown-like appearance, the coronavirus genome is the biggest among RNA viruses. There are about seven viruses capable of infecting humans: in the alpha genus, there are 229E and NL63, and in the beta genus, there are OC-43, HKU1, MERS-CoV, SARS-CoV, and SARS-CoV-2. The severe acute respiratory syndrome coronavirus (SARS-CoV) is a positive-stranded RNA virus. In humans, the virus is transmitted through respiratory tract droplets or discharges from diseased persons. The reservoir hosts for MERS-CoV are camels, while those for SARS-CoV are most likely bats. SARS-CoV-2 infecting a snake may have been transmitted by zoonotic transmission in a palm civet. The Chinese viruses SARS-Co- -2 and SARS-CoV have many things in common, including contact with wild animals.However, both SARS-CoV-2 and MERS-CoV have the ability to persist and spread the illness even when the infected individuals are untreated. SARS-S1 CoV-2's components of the spike proteins have 75% structural commonality with SARS-like CoVs in bats and SARS-CoV. According to genetic comparisons, the latest investigations have proven that SARS-CoV-2 targets angiotensin-converting enzyme type-2 (ACE-2) in humans. However, SARS-CoV-2 possesses an identical receptorbinding domain (RBD) pattern to SARS-CoV, with differences in amino acid sequences at certain vital positions. The RBD is also found in the C-domain S1 component of MERS-CoV's S protein (Spike). Conversely, in contrast to SARS-CoV, MERS-CoV uses a dipeptidyl-peptidase-4 (DPP-4) helix as its binding site. Similarly, MERS-RBD coronaviruses (CoVs) have an extra subdomain that functions as the receptor-binding motif (RBM).
Title: Mutations in SARS-CoV
Description:
The coronavirus family is named for the large spike protein molecules found on the pathogen exterior, which give the virus a crown-like appearance, the coronavirus genome is the biggest among RNA viruses.
There are about seven viruses capable of infecting humans: in the alpha genus, there are 229E and NL63, and in the beta genus, there are OC-43, HKU1, MERS-CoV, SARS-CoV, and SARS-CoV-2.
The severe acute respiratory syndrome coronavirus (SARS-CoV) is a positive-stranded RNA virus.
In humans, the virus is transmitted through respiratory tract droplets or discharges from diseased persons.
The reservoir hosts for MERS-CoV are camels, while those for SARS-CoV are most likely bats.
SARS-CoV-2 infecting a snake may have been transmitted by zoonotic transmission in a palm civet.
The Chinese viruses SARS-Co- -2 and SARS-CoV have many things in common, including contact with wild animals.
However, both SARS-CoV-2 and MERS-CoV have the ability to persist and spread the illness even when the infected individuals are untreated.
SARS-S1 CoV-2's components of the spike proteins have 75% structural commonality with SARS-like CoVs in bats and SARS-CoV.
According to genetic comparisons, the latest investigations have proven that SARS-CoV-2 targets angiotensin-converting enzyme type-2 (ACE-2) in humans.
However, SARS-CoV-2 possesses an identical receptorbinding domain (RBD) pattern to SARS-CoV, with differences in amino acid sequences at certain vital positions.
The RBD is also found in the C-domain S1 component of MERS-CoV's S protein (Spike).
Conversely, in contrast to SARS-CoV, MERS-CoV uses a dipeptidyl-peptidase-4 (DPP-4) helix as its binding site.
Similarly, MERS-RBD coronaviruses (CoVs) have an extra subdomain that functions as the receptor-binding motif (RBM).

Related Results

The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract Introduction Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...
Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2
Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2
SUMMARY The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein mediates infection of cells expressing angiotensin-con...
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
ABSTRACTThe COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-spe...
Modeling Coronavirus Spike Protein Dynamics: Implications for Immunogenicity and Immune Escape
Modeling Coronavirus Spike Protein Dynamics: Implications for Immunogenicity and Immune Escape
ABSTRACT The ongoing COVID-19 pandemic is a global public health emergency requiring urgent development of efficacious vaccines. While concentrated research efforts...

Back to Top